Balyasny Asset Management
AVNS

Balyasny Asset Management’s Avanos Medical AVNS Stock Holding History

Balyasny Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-86,229
Closed -$1.24M – 2812
2025
Q1 		$1.24M Buy
86,229
+71,620
+490% +$1.12M ﹤0.01% 1908
2024
Q4 		$233K Buy
+14,609
New +$289K ﹤0.01% 2485
2023
Q3 		– Sell
-13,182
Closed -$337K – 2246
2023
Q2 		$337K Buy
+13,182
New +$347K ﹤0.01% 1960
2022
Q4 		– Sell
-30,836
Closed -$672K – 2772
2022
Q3 		$672K Sell
30,836
-323,173
-91% -$8.44M ﹤0.01% 1949
2022
Q2 		$9.68M Buy
354,009
+65,163
+23% +$1.87M 0.03% 663
2022
Q1 		$9.68M Sell
288,846
-19,063
-6% -$614K 0.03% 706
2021
Q4 		$10.7M Sell
307,909
-23,085
-7% -$746K 0.04% 616
2021
Q3 		$10.3M Buy
+330,994
New +$11.2M 0.04% 565
2020
Q4 		– Sell
-207,941
Closed -$6.91M – 1313
2020
Q3 		$6.91M Buy
+207,941
New +$6.64M 0.05% 503
2019
Q4 		– Sell
-6,296
Closed -$236K – 1152
2019
Q3 		$236K Buy
+6,296
New +$240K ﹤0.01% 1058
2018
Q3 		– Sell
-6,317
Closed -$362K – 1655
2018
Q2 		$362K Buy
+6,317
New +$334K ﹤0.01% 1450
2018
Q1 		– Sell
-185,594
Closed -$8.57M – 1927
2017
Q4 		$8.57M Buy
+185,594
New +$8.53M 0.03% 682

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Balyasny Asset Management's AVNS Position: Q2 2025 in Review

Balyasny Asset Management sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 86,229 shares — an estimated $1.24M sold.

Balyasny Asset Management first reported a position in AVNS in Q4 2017 and held it in 12 quarters. The position peaked at $10.7M in Q4 2021. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Balyasny Asset Management reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 86,229 Avanos Medical shares in Q2 2025, an estimated $1.24M.
  • Balyasny Asset Management first reported a position in Avanos Medical in Q4 2017 and held it in 12 quarters.
  • Balyasny Asset Management's Avanos Medical position peaked at $10.7M in Q4 2021.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.